From discovery to delivery, the world’s leading pharmaceutical, medtech and in vitro diagnostic companies trust Phillips Medisize to help them design and commercialize lifesaving and enhancing technologies and therapy solutions. Phillips Medisize is a privately held global contract development and manufacturing organization (CDMO). The company’s 6,000+ employees collaborate with industry leaders and innovators across three continents and 29 development and manufacturing sites to design, engineering and manufacture drug delivery systems, medical devices and diagnostic tools that save and improve the quality of life for millions of patients annually.